Prostate cancer: Molecular imaging and MRI

被引：8
|
作者：
Moradi, Farshad [1 ]
Farolfi, Andrea [2 ]
Fanti, Stefano [2 ]
Iagaru, Andrei [1 ]
机构：
[1] Stanford Univ, Div Nucl Med & Mol Imaging, Dept Radiol, Stanford, CA 94305 USA
[2] Univ Bologna, Nucl Med Div, IRCCS Azienda Osped, Bologna, Italy
来源：
EUROPEAN JOURNAL OF RADIOLOGY | 2021年 / 143卷
关键词：
PET; MRI; F-18-Fluciclovine; C-11-Choline; Ga-68-PSMA; F-18-DCFPyL; Ga-68-RM2; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; SNMMI PROCEDURE GUIDELINE; SEMINAL-VESICLE INVASION; PET/CT JOINT EANM; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; C-11-CHOLINE PET/CT; BONE-SCINTIGRAPHY; RISK STRATIFICATION; GA-68-PSMA PET/CT;
D O I：
10.1016/j.ejrad.2021.109893
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The role of molecular imaging in initial evaluation of men with presumed or established diagnosis of prostate cancer and work up of biochemical recurrence and metastatic disease is rapidly evolving due to superior diagnostic performance compared to anatomic imaging. However, variable tumor biology and expression of transmembrane proteins or metabolic alterations poses a challenge. We review the evidence and controversies with emphasis on emerging PET radiopharmaceuticals and experience on clinical utility of PET/CT and PET/MRI in diagnosis and management of prostate cancer.
引用
收藏
页数：12
相关论文
共 50 条
  • [1] Prostate cancer imaging: MRI and nuclear imaging
    Penna, R. Renard
    Brenot-Rossi, I.
    Salomon, L.
    Soulie, M.
    PROGRES EN UROLOGIE, 2015, 25 (15): : 933 - 946
  • [2] Protein-Based MRI Contrast Agents for Molecular Imaging of Prostate Cancer
    Lixia Wei
    Shunyi Li
    Jianhua Yang
    Yiming Ye
    Jin Zou
    Liya Wang
    Robert Long
    Omar Zurkiya
    Tiejun Zhao
    Julian Johnson
    Jingjuan Qiao
    Wangda Zhou
    Adriana Castiblanco
    Natalie Maor
    Yanyi Chen
    Hui Mao
    Xiaoping Hu
    Jenny J. Yang
    Zhi-Ren Liu
    Molecular Imaging and Biology, 2011, 13 : 416 - 423
  • [3] Peptide targeted high-resolution molecular imaging of prostate cancer with MRI
    Wu, Xueming
    Yu, Guanping
    Lindner, Daniel
    Brady-Kalnay, Susann M.
    Zhang, Qi
    Lu, Zheng-Rong
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 4 (06): : 525 - 536
  • [4] Protein-Based MRI Contrast Agents for Molecular Imaging of Prostate Cancer
    Wei, Lixia
    Li, Shunyi
    Yang, Jianhua
    Ye, Yiming
    Zou, Jin
    Wang, Liya
    Long, Robert
    Zurkiya, Omar
    Zhao, Tiejun
    Johnson, Julian
    Qiao, Jingjuan
    Zhou, Wangda
    Castiblanco, Adriana
    Maor, Natalie
    Chen, Yanyi
    Mao, Hui
    Hu, Xiaoping
    Yang, Jenny J.
    Liu, Zhi-Ren
    MOLECULAR IMAGING AND BIOLOGY, 2011, 13 (03) : 416 - 423
  • [5] Molecular imaging of prostate cancer
    Boustani, Anne Marie
    Pucar, Darko
    Saperstein, Lawrence
    BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1084):
  • [6] Molecular Imaging of Prostate Cancer
    Wibmer, Andreas G.
    Burger, Irene A.
    Sala, Evis
    Hricak, Hedvig
    Weber, Wolfgang A.
    Vargas, Hebert Alberto
    RADIOGRAPHICS, 2016, 36 (01) : 142 - 159
  • [7] Molecular imaging in prostate cancer
    Karam, JA
    Mason, RP
    Koeneman, KS
    Antich, PP
    Benaim, EA
    Hsieh, JT
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 90 (03) : 473 - 483
  • [8] Molecular imaging of prostate cancer
    Emonds, K. M.
    Swinnen, J. V.
    Mortelmans, L.
    Mottaghy, F. M.
    METHODS, 2009, 48 (02) : 193 - 199
  • [9] Molecular imaging of prostate cancer
    Fox, Josef J.
    Schoeder, Heiko
    Larson, Steven M.
    CURRENT OPINION IN UROLOGY, 2012, 22 (04) : 320 - 327
  • [10] Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET
    Koo, Phillip J.
    Kwak, Jennifer J.
    Pokharel, Sajal
    Choyke, Peter L.
    CURRENT ONCOLOGY REPORTS, 2015, 17 (12)
12345